Spleen-preserving distal pancreatectomy following neoadjuvant chemotherapy for papillary solid and cystic neoplasm of pancreas

Ganesh Das; Chidananda Bhuyan; Bhabesh Kumar Das; Jagannath Deb Sharma; Bhargab Jyoti Saikia; Joydeep Purkystha

Spleen-preserving distal pancreatectomy following neoadjuvant chemotherapy for papillary solid and cystic neoplasm of pancreas

Indian J Gastroenterol. 2004 Sep-Oct;23(5):188-9.

Authors

Ganesh Das¹, Chidananda Bhuyan, Bhabesh Kumar Das, Jagannath Deb Sharma, Bhargab Jyoti Saikia, Joydeep Purkystha

Affiliation

¹ Department of Surgical Oncology, Dr Bhabaneswar Borooah Cancer Institute, Gopinath Nagar, Guwahati-781 016, Assam, India. gdas7798@indiatimes.com

PMID: 15599007

Abstract

Papillary solid and cystic neoplasm (PSCN) is a rare neoplasm of the pancreas with low-grade malignant potential and favorable prognosis. We report an 18-year-old girl with PSCN presenting with advanced disease. The tumor regressed with six cycles of gemcitabine and cisplantin-based neoadjuvant chemotherapy; spleen-preserving distal pancreatectomy was then done. She is disease-free at 13 months' follow-up.

Publication types

Case Reports

MeSH terms

Abdominal Pain / diagnosis
Abdominal Pain / etiology
Adolescent
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Carcinoma, Papillary / diagnosis
Carcinoma, Papillary / drug therapy
Carcinoma, Papillary / surgery*
Combined Modality Therapy
Cystadenoma, Papillary / diagnosis
Cystadenoma, Papillary / drug therapy
Cystadenoma, Papillary / surgery*
Female
Follow-Up Studies
Humans
Neoadjuvant Therapy
Pancreatectomy / methods*
Pancreatic Neoplasms / drug therapy
Pancreatic Neoplasms / pathology
Pancreatic Neoplasms / surgery*
Risk Assessment
Spleen
Tomography, X-Ray Computed
Treatment Outcome